+1 786 523 0113 +49 32 2122 49284 +420 723 850 509

SS-31 Research

Cardiolipin-Targeting Mitochondrial Peptide

mitochondrial function

Rejuvenation Immune Support, Training and Energy Spike Protein Research
Nur Bildungsinformationen. Experimentelle Anwendungen haben möglicherweise keine FDA-Zulassung. Keine medizinische Beratung oder Behandlungsplan.

SS-31 (elamipretide) is a synthetic aromatic-cationic tetrapeptide that selectively concentrates in the inner mitochondrial membrane, where it binds cardiolipin — a phospholipid critical to mitochondrial architecture and function. It is studied for its role in mitochondrial integrity research, cellular energy pathway signaling, and protection against oxidative stress. Clinical trials have evaluated it in heart failure and other conditions involving mitochondrial dysfunction.

Cardiolipin & Mitochondrial Membrane Research Research investigates SS-31's interaction with cardiolipin in the inner mitochondrial membrane, exploring how this binding affects cristae structure, membrane potential maintenance, and electron transport chain efficiency research.
Mitochondrial Energy Production Signaling Studies examine its effects on ATP synthase activity, electron transport chain complex signaling, and mitochondrial respiratory efficiency pathway research under conditions of metabolic stress.
Reactive Oxygen Species & Oxidative Stress Research Researchers study SS-31's role in reducing mitochondrial ROS generation, exploring its interaction with cytochrome c and superoxide signaling pathways in the context of oxidative damage research.
Cardiac Function Pathway Research Clinical and preclinical studies investigate its effects on cardiomyocyte energy signaling, mitochondrial function in heart failure models, and cardiac remodeling pathway research.
Neuroprotective & Aging Research Studies explore SS-31's potential protective effects on neuronal mitochondrial function, age-related mitochondrial decline signaling, and neurodegenerative disease-related energy pathway research.

Investigational compound (elamipretide). Clinical trials have been conducted in heart failure. Not FDA-approved for general use. Not medical advice.

Haben Sie Fragen zu SS-31?

Fordern Sie eine kostenlose Beratung an, um Fragen zu stellen und mehr über diesen Forschungsbereich zu erfahren.

Kostenlose Beratung anfordern

← Zurück zu allen Themen